Medical Condition News

RSS

Varian receives marketing approval for TrueBeam image-guided radiotherapy and radiosurgery system in Japan

Varian Medical Systems, Inc., the world's leading manufacturer of medical technology for treating cancer with radiotherapy, announced today it has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the TrueBeam™ system for image-guided radiotherapy and radiosurgery in Japan.

15 Jun 2011

Overactive mTOR can result in serious disruption of kidney filter in diabetes patients

Diabetes mellitus is one of the most common secondary diseases in modern society. And because it is on the rise, it is also one of the greatest challenges facing medicine today. Diabetes patients do not die as a direct result of the increase in blood sugar, but from the long-term complications of their disease, in which the increase in blood sugar causes damage to blood vessels and organs.

15 Jun 2011

Childhood cancer survivors at increased risk of new cancers in middle age

CANCER RESEARCH UK scientists have found that survivors of childhood cancers are four times more likely than the general population to develop a new cancer. The results are published online today in JAMA.

15 Jun 2011

Scientists zero in on dose levels of "sacred mushroom"

Scientists at the Johns Hopkins University School of Medicine have zeroed in on the dose levels of the "sacred mushroom" chemical capable of yielding positive, life-changing experiences, while minimizing the chance of transient negative reactions in screened volunteers under supportive, carefully monitored conditions.

15 Jun 2011

Long carbon nanotubes could cause cancer in the lung lining

Tiny fibres used to strengthen everyday products such as bicycle frames and hockey sticks could pose health hazards to those involved in their manufacture.

15 Jun 2011

Statistics of breast cancer risk

Sometimes it can be difficult to understand people talking about cancer, especially doctors, scientists, and reporters. Part of the reason is because they use so many numbers and statistics without explaining exactly what they mean. A famous philosopher once said that "Mathematics is the language of science." But most of us don't speak that language very well. Here are some ways to think about the numbers that professionals may use when talking about cancer.

15 Jun 2011

FDA issues final rulemaking on testing and labeling of sunscreen products

"FDA's recognition today of the important role sunscreens play in protecting the public not only from sunburn but also from skin cancer and premature aging due to the sun is a very significant victory for public health. The role of UV rays in causing skin damage and the role of sunscreens in protecting against this sun damage are widely acknowledged within the medical and scientific communities, and we're very pleased the agency has taken this critical step.

15 Jun 2011

California's rural elders more likely to be obese, physically inactive and food insecure

Despite living in the countryside, where open space is plentiful and there is often significant agricultural production, California's more than half a million rural elders are far more likely to be overweight or obese, physically inactive and food insecure than their suburban counterparts, according to a new policy brief from the UCLA Center for Health Policy Research.

15 Jun 2011

Nuvilex to acquire live cell encapsulation technology for multiple cancer therapies

Nuvilex, Inc. announced today it has entered into discussions to acquire the next generation live cell encapsulation technology that serves as the platform for multiple cancer therapies.

15 Jun 2011

Precise method to determine age of bruises

Forensic scientists have to rely on their own subjective experience when asked to ascertain the age of contusions. Now, however, researchers in Norway have found a far more objective and precise method.

15 Jun 2011

Leukothera effectively treats psoriasis in humanized mouse xenograft transplantation model

Psoriasis is a persistent, long-lasting chronic skin disease affecting 2-3 percent of the world's population or more than 125 million individuals. For some, it is just a nuisance. For others, it is disabling.

15 Jun 2011

Hanger Orthopedic to deploy NextGen Ambulatory EHR and Practice Management

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today that Hanger Orthopedic Group, Inc. will deploy NextGen Ambulatory EHR and NextGen Practice Management.

15 Jun 2011

High FGF-23 hormone levels linked to increased risk of end-stage renal disease and death

Patients in the early stages of chronic kidney disease who had elevated levels of the endocrine hormone fibroblast growth factor 23 (that regulates phosphorus metabolism) had an associated increased risk of end-stage renal disease and death, according to a study in the June 15 issue of JAMA.

15 Jun 2011

John Theurer Cancer Center, LRF partner for Philadelphia Lymphoma Rounds program

On June 15, the Lymphoma Research Foundation (LRF), in collaboration with the John Theurer Cancer Center at Hackensack University Medical Center, will bring together lymphoma experts to discuss the latest practices in the diagnosis and management of lymphoma.

15 Jun 2011

HTX provides $750,000 funding to Profound Medical through Technology Assessment Program

HTX, a member of the Canadian Venture Capital Association, announced today it provided $750,000 in financing to Profound Medical Inc. through their Technology Assessment Program.

15 Jun 2011

ESC publishes position paper to raise the profile of vulnerable plaques

The European Society of Cardiology (ESC) Working Group of Atherosclerosis and Vascular Biology has published a position paper to raise the profile of vulnerable plaques and the need for greater use of therapies to promote plaque stabilisation.

15 Jun 2011

Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer

A type of virus known as the human reovirus possesses a remarkable trait: It can replicate inside and kill cancer cells that feature a common mutation, while leaving the body's normal cells alone.

15 Jun 2011

Researchers reveal how anti-arrhythmic drugs control irregular heartbeats

University of British Columbia researchers - using an innovative, atom-by-atom substitution method - have uncovered the mechanism by which a particular class of drugs controls irregular heartbeats.

15 Jun 2011

immatics initiates IMA901 Phase III trial in renal cell carcinoma

igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.

15 Jun 2011

Meda presents new positive results from Dymista Phase-III trial on AR at EAACI 2011

Meda presents new positive results from a Phase-III clinical trial of Dymista at the annual meeting of the European Academy of Allergy and Clinical Immunology (EAACI) in Istanbul, Turkey.

15 Jun 2011

Medical Condition News

Varian receives marketing approval for TrueBeam image-guided radiotherapy and radiosurgery system in Japan

Overactive mTOR can result in serious disruption of kidney filter in diabetes patients

Childhood cancer survivors at increased risk of new cancers in middle age

Scientists zero in on dose levels of "sacred mushroom"

Long carbon nanotubes could cause cancer in the lung lining

Statistics of breast cancer risk

FDA issues final rulemaking on testing and labeling of sunscreen products

California's rural elders more likely to be obese, physically inactive and food insecure

Nuvilex to acquire live cell encapsulation technology for multiple cancer therapies

Precise method to determine age of bruises

Leukothera effectively treats psoriasis in humanized mouse xenograft transplantation model

Hanger Orthopedic to deploy NextGen Ambulatory EHR and Practice Management

High FGF-23 hormone levels linked to increased risk of end-stage renal disease and death

John Theurer Cancer Center, LRF partner for Philadelphia Lymphoma Rounds program

HTX provides $750,000 funding to Profound Medical through Technology Assessment Program

ESC publishes position paper to raise the profile of vulnerable plaques

Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer

Researchers reveal how anti-arrhythmic drugs control irregular heartbeats

immatics initiates IMA901 Phase III trial in renal cell carcinoma

Meda presents new positive results from Dymista Phase-III trial on AR at EAACI 2011

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News